M Lafrenz

991 total citations
23 papers, 704 citations indexed

About

M Lafrenz is a scholar working on Epidemiology, Hepatology and Sociology and Political Science. According to data from OpenAlex, M Lafrenz has authored 23 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 12 papers in Hepatology and 5 papers in Sociology and Political Science. Recurrent topics in M Lafrenz's work include Hepatitis C virus research (10 papers), Liver Disease Diagnosis and Treatment (9 papers) and Hepatitis B Virus Studies (7 papers). M Lafrenz is often cited by papers focused on Hepatitis C virus research (10 papers), Liver Disease Diagnosis and Treatment (9 papers) and Hepatitis B Virus Studies (7 papers). M Lafrenz collaborates with scholars based in Germany, Austria and Norway. M Lafrenz's co-authors include H. Porst, Manfred Wiese, U. Oesen, Frieder Berr, Matthias Niedrig, Petra Emmerich, W Güthoff, Kurt Grüngreiff, Thomas Berg and G Teuber and has published in prestigious journals such as Hepatology, Journal of Hepatology and American Journal of Tropical Medicine and Hygiene.

In The Last Decade

M Lafrenz

22 papers receiving 683 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Lafrenz Germany 11 506 504 125 98 42 23 704
J Slusarczyk Poland 14 444 0.9× 285 0.6× 90 0.7× 28 0.3× 38 0.9× 71 622
Nicole Simon France 10 406 0.8× 440 0.9× 106 0.8× 24 0.2× 26 0.6× 12 577
Sisira Pathirana Sri Lanka 8 293 0.6× 212 0.4× 49 0.4× 189 1.9× 24 0.6× 14 509
Vito Scalia Canada 16 337 0.7× 265 0.5× 161 1.3× 97 1.0× 7 0.2× 34 745
Bencha Petchclai Thailand 7 213 0.4× 156 0.3× 104 0.8× 84 0.9× 14 0.3× 17 400
G. Dal Molin Italy 13 319 0.6× 239 0.5× 97 0.8× 25 0.3× 14 0.3× 29 480
Namiko Yoshihara Japan 12 436 0.9× 385 0.8× 138 1.1× 33 0.3× 5 0.1× 29 691
Ellen B. Hunter United States 8 289 0.6× 443 0.9× 51 0.4× 19 0.2× 38 0.9× 9 621
Kirsten A. Visoná United States 10 533 1.1× 504 1.0× 171 1.4× 23 0.2× 8 0.2× 22 671
Ming Chang United States 12 214 0.4× 208 0.4× 191 1.5× 83 0.8× 16 0.4× 30 585

Countries citing papers authored by M Lafrenz

Since Specialization
Citations

This map shows the geographic impact of M Lafrenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Lafrenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Lafrenz more than expected).

Fields of papers citing papers by M Lafrenz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Lafrenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Lafrenz. The network helps show where M Lafrenz may publish in the future.

Co-authorship network of co-authors of M Lafrenz

This figure shows the co-authorship network connecting the top 25 collaborators of M Lafrenz. A scholar is included among the top collaborators of M Lafrenz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Lafrenz. M Lafrenz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dennin, Reinhard H., et al.. (2014). HIV and Other Sexual Transmitted Infections—Challenges for Liberal Prevention Strategies. World Journal of AIDS. 4(2). 258–279. 1 indexed citations
2.
3.
Dennin, Reinhard H., et al.. (2011). Dilemma of concepts and strategies for the prevention of spread of HIV in relation to human behavior, law and human rights. Journal of Zhejiang University SCIENCE B. 12(7). 591–610. 1 indexed citations
4.
Kundt, Günther, et al.. (2010). Der Wissensstand von Schülern über das Thema HIV/AIDS an ausgewählten Schulen in Mecklenburg-Vorpommern. Das Gesundheitswesen. 73(1). e21–e26. 6 indexed citations
5.
Dennin, Reinhard H., et al.. (2009). Die Prävention der HIV-Infektion: Ethik und Recht sind nicht mehr gefragt?. Medizinrecht. 27(8). 457–463. 1 indexed citations
6.
Witthöft, T, B Möller, K. H. Wiedmann, et al.. (2007). Safety, tolerability and efficacy of peginterferon alpha‐2a and ribavirin in chronic hepatitis C in clinical practice: The German Open Safety Trial. Journal of Viral Hepatitis. 14(11). 788–796. 44 indexed citations
7.
Hemmer, Christoph Josef, Martina Littmann, Micha Löbermann, et al.. (2005). Ein Fall einer autochthonen Frühsommermeningoenzephalitis (FSME) in Mecklenburg-Vorpommern. DMW - Deutsche Medizinische Wochenschrift. 130(44). 2507–2511. 2 indexed citations
8.
Wiese, Manfred, Kurt Grüngreiff, W Güthoff, et al.. (2005). Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany—a 25-year multicenter study. Journal of Hepatology. 43(4). 590–598. 128 indexed citations
9.
Kirchhoff, Anne C., et al.. (2004). Beidseitige AION nach einer Kombinationstherapie mit PEG-Interferon Alpha-2 b und Ribavirin bei Hepatitis C. Klinische Monatsblätter für Augenheilkunde. 221(9). 791–793. 10 indexed citations
10.
Loebermann, Micha, Herwig Kollaritsch, Pamela Rendi‐Wagner, et al.. (2004). A randomized, open-label study of the immunogenicity and reactogenicity of three lots of a combined typhoid fever/hepatitis A vaccine in healthy adults. Clinical Therapeutics. 26(7). 1084–1091. 11 indexed citations
11.
Teuber, G, M. Pascu, Thomas Berg, et al.. (2003). Randomized, controlled trial with IFN-α combined with ribavirin with and without amantadine sulphate in non-responders with chronic hepatitis C. Journal of Hepatology. 39(4). 606–613. 34 indexed citations
12.
Tintelnot, Kathrin, et al.. (2002). Histoplasmose-Gruppenerkrankung bei Fledermausforschern nach Kubaaufenthalt. DMW - Deutsche Medizinische Wochenschrift. 127(01/02). 21–25. 18 indexed citations
13.
14.
15.
16.
Teuber, G, Thomas Berg, Robert M. Hoffmann, et al.. (2000). Retreatment with Interferon-Alpha and Ribavirin in Primary Interferon-Alpha Non-Responders with Chronic Hepatitis C. Digestion. 61(2). 90–97. 19 indexed citations
17.
Wiese, Manfred, Frieder Berr, M Lafrenz, H. Porst, & U. Oesen. (2000). Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in germany: A 20-year multicenter study. Hepatology. 32(1). 91–96. 249 indexed citations
18.
19.
Lafrenz, M, et al.. (1995). [Splenic rupture in infectious mononucleosis].. PubMed. 89(7). 725–8. 2 indexed citations
20.
Goilav, Christian, Jane N. Zuckerman, M Lafrenz, et al.. (1995). Immunogenicity and safety of a new inactivated hepatitis a vaccine in a comparative study. Journal of Medical Virology. 46(3). 287–292. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Slusarczyk Breakdown of academic impact, for papers by Nicole Simon Breakdown of academic impact, for papers by Sisira Pathirana Breakdown of academic impact, for papers by Vito Scalia Breakdown of academic impact, for papers by Bencha Petchclai Breakdown of academic impact, for papers by G. Dal Molin Breakdown of academic impact, for papers by Namiko Yoshihara Breakdown of academic impact, for papers by Ellen B. Hunter Breakdown of academic impact, for papers by Kirsten A. Visoná Breakdown of academic impact, for papers by Ming Chang
Rankless by CCL
2026